Skip to main content

Gerald Bloomfield

Associate Professor of Medicine
Medicine, Cardiology
Department of Medicine, DUMC Box 3850, Durham, NC 27705
200 Morris Street, Durham, NC 27701

Overview


Gerald Bloomfield, MD, MPH, joined the faculty in Medicine and Global Health after completing his Cardiovascular Medicine fellowship training at Duke University Medical Center and Duke Clinical Research Institute. Bloomfield also completed the Duke Global Health Residency/Fellowship Pathway and a Fogarty International Clinical Research Fellowship. He received his medical education, internal medicine residency and Master of Public Health degree from Johns Hopkins University. Bloomfield leads a longstanding research and capacity building program on cardiovascular global health which includes work in under-resourced communities in the US and a number of low- and middle-income country settings.

Current Appointments & Affiliations


Associate Professor of Medicine · 2021 - Present Medicine, Cardiology, Medicine
Associate Director for Research at Duke Global Health Institute · 2023 - Present Duke Global Health Institute, University Institutes and Centers
Associate Research Professor of Global Health · 2021 - Present Duke Global Health Institute, University Institutes and Centers
Member in the Duke Clinical Research Institute · 2011 - Present Duke Clinical Research Institute, Institutes and Centers

Recent Publications


Virtual adaptation of a nurse-driven strategy to improve blood pressure control among people with HIV.

Journal Article HIV Res Clin Pract · December 2025 People with HIV are at increased risk of cardiovascular events; thus, care delivery strategies that increase access to comprehensive cardiovascular disease (CVD) risk management are a priority. We report the results of a multi-component telemedicine-based ... Full text Link to item Cite

Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis.

Journal Article The lancet. HIV · June 2025 BackgroundIn the REPRIEVE trial of statin therapy in people with HIV, pitavastatin reduced major adverse cardiovascular events (MACE) among those with low-to-moderate risk of cardiovascular disease (CVD). We aimed to investigate associations betwe ... Full text Cite

Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial.

Journal Article AIDS · May 23, 2025 OBJECTIVE: People with HIV (PWH) are at increased risk of sudden cardiac death (SCD) but the mechanisms are unclear limiting prevention efforts. We leveraged the global REPRIEVE trial with carefully adjudicated atherosclerotic cardiovascular disease (ASCVD ... Full text Link to item Cite
View All Publications

Recent Grants


GE Precision Healthcare, LLC Work Statement# A-13 (RURAL ECHO)

ResearchPrincipal Investigator · Awarded by GE Precision Healthcare LLC · 2025 - 2027

REPRIEVE Extension for Trial Completion

ResearchCo Investigator · Awarded by Massachusetts General Hospital · 2023 - 2026

View All Grants

Education, Training & Certifications


Johns Hopkins University, School of Medicine · 2002 M.D.